Similar articles for PMID: 30316074

Year	Number of Results
1878	1
1968	1
1969	1
1972	1
1979	2
1981	1
1987	1
1989	1
1990	1
1992	1
1994	1
1995	2
1996	3
1997	1
1998	2
1999	2
2000	1
2001	4
2002	1
2003	2
2004	6
2005	3
2006	3
2007	2
2008	2
2009	2
2010	6
2011	3
2012	7
2013	8
2014	1
2015	4
2016	5
2017	4
2018	2
2019	4
2020	2
2021	1
2023	1
2024	0

1

Ketotifen fumarate attenuates feline gingivitis related with gingival microenvironment modulation.

Yuan W, Hou S, Jia H, Qiu Z, Liu T, Chen X, Li H, Sun Y, Liang L, Sui X, Zhao X, Zhao Z. Yuan W, et al. Int Immunopharmacol. 2018 Dec;65:159-173. doi: 10.1016/j.intimp.2018.10.006. Epub 2018 Oct 10. Int Immunopharmacol. 2018. PMID: 30316074

2

Ketotifen induced inhibition of histamine release in a non-IgE model of middle ear effusion.

Berger G, Berger R, Goldberg A. Berger G, et al. Pediatr Allergy Immunol. 2006 Feb;17(1):43-8. doi: 10.1111/j.1399-3038.2005.00350.x. Pediatr Allergy Immunol. 2006. PMID: 16426254

3

Ketotifen fumarate treatment of superior limbic keratoconjunctivitis.

Udell IJ, Guidera AC, Madani-Becker J. Udell IJ, et al. Cornea. 2002 Nov;21(8):778-80. doi: 10.1097/00003226-200211000-00009. Cornea. 2002. PMID: 12410035

4

Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of Nf1-Deficient Mice.

Burks CA, Rhodes SD, Bessler WK, Chen S, Smith A, Gehlhausen JR, Hawley ET, Jiang L, Li X, Yuan J, Lu Q, Jacobsen M, Sandusky GE, Jones DR, Clapp DW, Blakeley JO. Burks CA, et al. Mol Cancer Ther. 2019 Dec;18(12):2321-2330. doi: 10.1158/1535-7163.MCT-19-0123. Epub 2019 Sep 16. Mol Cancer Ther. 2019. PMID: 31527226 Free PMC article.

5

Mast cell stabilizer ketotifen [4-(1-methyl-4-piperidylidene)-4h-benzo[4,5]cyclohepta[1,2-b]thiophen-10(9H)-one fumarate] prevents mucosal mast cell hyperplasia and intestinal dysmotility in experimental Trichinella spiralis inflammation in the rat.

Serna H, Porras M, Vergara P. Serna H, et al. J Pharmacol Exp Ther. 2006 Dec;319(3):1104-11. doi: 10.1124/jpet.106.104620. Epub 2006 Sep 20. J Pharmacol Exp Ther. 2006. PMID: 16988056

6

Therapeutic potential of ketotifen in irritable bowel syndrome (IBS) may involve changes in mast cells at sites beyond the rectum.

O'Sullivan M. O'Sullivan M. Gut. 2011 Mar;60(3):423; author rpely 423. doi: 10.1136/gut.2010.225078. Epub 2010 Oct 4. Gut. 2011. PMID: 20921205 No abstract available.

7

In vitro inhibition of human conjunctival mast-cell degranulation by ketotifen.

Schoch C. Schoch C. J Ocul Pharmacol Ther. 2003 Feb;19(1):75-81. doi: 10.1089/108076803762718132. J Ocul Pharmacol Ther. 2003. PMID: 12648306

8

The mast cell stabilizer ketotifen fumarate lessens contracture severity and myofibroblast hyperplasia: a study of a rabbit model of posttraumatic joint contractures.

Monument MJ, Hart DA, Befus AD, Salo PT, Zhang M, Hildebrand KA. Monument MJ, et al. J Bone Joint Surg Am. 2010 Jun;92(6):1468-77. doi: 10.2106/JBJS.I.00684. J Bone Joint Surg Am. 2010. PMID: 20516323 Free PMC article.

9

Comparison of the efficacy of KOB03, ketotifen, and montelukast in an experimental mouse model of allergic rhinitis.

Jung HW, Jung JK, Park YK. Jung HW, et al. Int Immunopharmacol. 2013 Jun;16(2):254-60. doi: 10.1016/j.intimp.2013.04.011. Epub 2013 May 1. Int Immunopharmacol. 2013. PMID: 23643816

10

Ketotifen abrogates local and systemic consequences of rat intestinal ischemia-reperfusion injury.

Kalia N, Brown NJ, Wood RF, Pockley AG. Kalia N, et al. J Gastroenterol Hepatol. 2005 Jul;20(7):1032-8. doi: 10.1111/j.1440-1746.2005.03767.x. J Gastroenterol Hepatol. 2005. PMID: 15955211

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

87 results

Results by year